Peru has signed an amendment to the
with the aim of acquiring 35 million vaccine doses against COVID-19 in 2022, the
In this sense, it strengthened Peru's partnership with said laboratory in order to continue receiving this high-quality vaccine next year.
The signing of the amendment ensures the supply of 35 million additional doses, so that these can be administered within the framework of the National Vaccination Plan.
Likewise, it reflects the Peruvian Government's commitment to ensuring the supply of doses against COVID-19 to put an end to the pandemic.